Guide-free Cas9 from pathogenic Campylobacter jejuni bacteria causes severe damage to DNA
Author(s) -
Chinmoy Saha,
Prarthana Mohanraju,
Andrew Stubbs,
Gaurav Dugar,
Youri Hoogstrate,
GertJan Kremers,
Wiggert A. van Cappellen,
Deborah Horst-Kreft,
Charlie Laffeber,
Joyce H.G. Lebbink,
Serena T. Bruens,
Duncan J. H. Gaskin,
Dior Beerens,
Maarten Klunder,
Rob Joosten,
Jeroen Demmers,
Dik C. van Gent,
Johan W. Mouton,
Peter J. van der Spek,
John van der Oost,
Peter van Baarlen,
Rogier Louwen
Publication year - 2020
Publication title -
science advances
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.928
H-Index - 146
ISSN - 2375-2548
DOI - 10.1126/sciadv.aaz4849
Subject(s) - campylobacter jejuni , microbiology and biotechnology , dna damage , pathogenic bacteria , dna , bacteria , campylobacter , biology , genetics
CRISPR-Cas9 systems are enriched in human pathogenic bacteria and have been linked to cytotoxicity by an unknown mechanism. Here, we show that upon infection of human cells, secretes its Cas9 (CjeCas9) nuclease into their cytoplasm. Next, a native nuclear localization signal enables CjeCas9 nuclear entry, where it catalyzes metal-dependent nonspecific DNA cleavage leading to cell death. Compared to CjeCas9, native Cas9 of (SpyCas9) is more suitable for guide-dependent editing. However, in human cells, native SpyCas9 may still cause some DNA damage, most likely because of its ssDNA cleavage activity. This side effect can be completely prevented by saturation of SpyCas9 with an appropriate guide RNA, which is only partially effective for CjeCas9. We conclude that CjeCas9 plays an active role in attacking human cells rather than in viral defense. Moreover, these unique catalytic features may therefore make CjeCas9 less suitable for genome editing applications.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom